Trial Outcomes & Findings for Implant Placement With Simultaneous Gum Grafting (NCT NCT01431144)
NCT ID: NCT01431144
Last Updated: 2017-02-01
Results Overview
Soft tissue thickness at the facial osseous crest.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
27 participants
Primary outcome timeframe
1 year
Results posted on
2017-02-01
Participant Flow
27 patients were entered, 13 for the test allograft group and 14 for the positive control connective tissue autograft group
There were no exclusions prior to assignment or treatment.
Participant milestones
| Measure |
Connective Tissue Allograft
A connective tissue allograft was placed simultaneously with dental implant placement and soft tissue thickness was measured at baseline and Time 4.
|
Connective Tissue Autograft
A connective tissue autograft was placed simultaneously with dental implant placement and soft tissue thickness was measured at baseline and Time 4.
|
|---|---|---|
|
Overall Study
STARTED
|
13
|
14
|
|
Overall Study
COMPLETED
|
11
|
14
|
|
Overall Study
NOT COMPLETED
|
2
|
0
|
Reasons for withdrawal
| Measure |
Connective Tissue Allograft
A connective tissue allograft was placed simultaneously with dental implant placement and soft tissue thickness was measured at baseline and Time 4.
|
Connective Tissue Autograft
A connective tissue autograft was placed simultaneously with dental implant placement and soft tissue thickness was measured at baseline and Time 4.
|
|---|---|---|
|
Overall Study
Implant mobility and removal
|
2
|
0
|
Baseline Characteristics
Implant Placement With Simultaneous Gum Grafting
Baseline characteristics by cohort
| Measure |
Connective Tissue Allograft
n=13 Participants
A connective tissue allograft was placed simultaneously with dental implant placement and soft tissue thickness was measured at baseline and Time 4.
|
Connective Tissue Autograft
n=14 Participants
A connective tissue autograft was placed simultaneously with dental implant placement and soft tissue thickness was measured at baseline and Time 4.
|
Total
n=27 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
10 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
19 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
3 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
8 Participants
n=5 Participants
|
|
Age, Continuous
|
46 years
STANDARD_DEVIATION 21 • n=5 Participants
|
57 years
STANDARD_DEVIATION 10 • n=7 Participants
|
52 years
STANDARD_DEVIATION 16 • n=5 Participants
|
|
Gender
Female
|
7 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
16 Participants
n=5 Participants
|
|
Gender
Male
|
6 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
11 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
13 participants
n=5 Participants
|
14 participants
n=7 Participants
|
27 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 1 yearSoft tissue thickness at the facial osseous crest.
Outcome measures
| Measure |
Connective Tissue Allograft
n=11 Participants
A connective tissue allograft was placed simultaneously with dental implant placement and soft tissue thickness was measured at baseline and Time 4.
|
Connective Tissue Autograft
n=14 Participants
A connective tissue autograft was placed simultaneously with dental implant placement and soft tissue thickness was measured at baseline and Time 4.
|
|---|---|---|
|
Soft Tissue Thickness Over the Implant
|
0.6 mm
Standard Deviation 1.2
|
0.4 mm
Standard Deviation 0.7
|
Adverse Events
Connective Tissue Allograft
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Connective Tissue Autograft
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Henry Greenwell, Principal Investigator
University of Louisville
Phone: 502-852-6928
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place